16:45 EDT First Wave CEO says in process of capital raise, sees share price going up
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FWBI:
- First Wave Bio Inc. Grapples with Uncertainty in Pending Niclosamide Deal
- First Wave BioPharma reinstated with a Neutral at H.C. Wainwright
- First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
- First Wave BioPharma announces acceptance of two abstracts on celiac disease
- First Wave BioPharma price target lowered to $36 from $40 at Roth MKM